SCHEMBL27747809

SCHEMBL27747809

COCCNc1cc(F)c(Nc2cc(OC3CCNCC3)ncn2)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 2/20 0.39
FLT3 P36888 3/20 0.38
CDK2 P24941 2/20 0.38
CDK6 Q00534 2/20 0.38
CCNT1 O60563 1/20 0.38
CCNA2 P20248 1/20 0.38
CCND3 P30281 1/20 0.38
CDK7 P50613 1/20 0.38
CDK9 P50750 1/20 0.38
CCNH P51946 1/20 0.38
MNAT1 P51948 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
EGFR P00533 5/20 0.34
DGAT1 O75907 1/20 0.34
SOAT1 P35610 1/20 0.34
KHK P50053 1/20 0.34
DYRK1A Q13627 1/20 0.34
KDR P35968 4/20 0.33
FGFR1 P11362 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046883 0.88 GPR119 (0.39) GPR119FLT3CDK2CDK6CCNT1
SCHEMBL5049760 0.85 GPR119 (0.43) GPR119FLT3CDK2CDK6CCNT1
SCHEMBL5264798 0.81 GPR119 (0.41) GPR119FLT3CDK2CDK6CCNT1
SCHEMBL388438 0.80 GPR119 (0.66) GPR119
SCHEMBL5048550 0.79 GPR119 (0.49) GPR119FLT3CDK2CDK6CCNT1
SCHEMBL4719555 0.78 GPR119 (0.52) GPR119FLT3CDK2CDK6DGAT1
SCHEMBL4269127 0.78 CSNK2A2 (0.43) GPR119FLT3CDK2CDK6CCNT1
SCHEMBL5049360 0.77 GPR119 (0.37) GPR119FLT3CDK2CDK6CCNT1
SCHEMBL5046882 0.76 GPR119 (0.46) GPR119FLT3CDK2CDK6CCNT1
SCHEMBL3672449 0.74 GPR119 (0.67) GPR119CDK2CDK6CCNT1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101420941-A Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, and related combination therapies ARENA PHARM INC (US) 2009-04-29 CN disclosed